Buying a Pharmacy Business With Commercial Property in Alberta

1. Define the buyer, entities and acquisition perimeter

Identify the proposed ownership, major shareholders, proprietor's representative, licensee and operating entity. Separate shares, operating assets, drug and front-store inventory, records, contracts, leasehold rights and real estate, and state which items are excluded.

A trade name, pharmacy sign or seller licence does not establish ownership of the corporation, patient records, drugs, equipment, lease or land. Use corporate, licence, title, lease, contract and asset records to map each right.

• Shares or assets
• ACP approval path
• Licensee
• Drugs and front store
• Records and systems
• Lease or real estate

2. Build the ACP ownership and licence path before closing

ACP treats a sale of pharmacy assets to a new person or entity, and certain changes involving major shareholders, as a proprietorship change requiring advance notice and approval. ACP recommends applying at least 45 days before the intended change, but that is a planning recommendation—not a promised approval date.

Review the seller's licence conditions, inspection history, action items, renovations, approved floor plan, shared-premises status, compounding activities and record-storage arrangements. The seller's licence and history are diligence evidence; they are not buyer approval and do not transfer automatically.

3. Confirm the licensee and proprietor responsibilities

ACP describes the licensee as personally responsible for managing, controlling and supervising the pharmacy's operation and practice. Document the proposed licensee's eligibility, authority, availability, employment or ownership relationship and transition plan.

Do not treat a departing licensee's name, credentials or established practices as an asset that automatically continues. Tie regulatory responsibility, staffing, policies, keys, systems, records and readiness to the people who will actually operate after closing.

4. Rebuild revenue from source systems

Separate prescription dispensing, professional or clinical services, front-store sales, delivery, compounding and other activities. Reconcile dispensing and point-of-sale exports to third-party payer remittances, receivables, reversals, merchant settlements, bank deposits, GST records and the general ledger.

Prescription count is not revenue, gross profit or collected cash. Distinguish billed, adjudicated, reversed, rejected, unpaid and collected amounts, ingredient cost, dispensing or professional fees, patient co-payments and timing differences.

5. Test earnings, payer exposure and working capital

Analyze drug costs, wholesaler terms, rebates or credits, labour, rent, software, delivery, insurance, security, professional services, shrink, bad debts and owner compensation. Reconcile payer receivables and liabilities by period and counterparty.

Patient relationships and historical scripts are not owned demand or guaranteed future volume. Present historical results, documented adjustments and buyer forecasts separately, and have accounting and valuation professionals interpret the evidence.

6. Count inventory by regulatory and economic category

Create dated schedules for prescription drugs, controlled substances, narcotics, refrigerated items, compounds, returns, quarantined or expired product and front-store goods. Capture quantity, source, cost, expiry, condition, ownership and proposed closing treatment.

Drug count is not transferable or saleable inventory value. Health Canada's community-pharmacy guidance addresses controlled-substance security, reconciliation and records, including an inventory after an owner or manager change; coordinate the actual count and transfer process with pharmacists, ACP, Health Canada requirements, counsel and accountants.

7. Protect patient records and health information

Map the custodian, information manager arrangements, systems, paper and off-site records, backups, access logs and proposed transition. Use a staged, necessary and documented diligence process rather than opening patient-level information to ordinary buyer review.

Patient records are not ordinary sale assets. ACP states that a non-regulated proprietor cannot become custodian of or access patient records when a pharmacy closes; obtain specialized privacy and health-law advice for any custody, system or records transition.

8. Verify the dispensary, floor plan and proposed services

Compare the actual premises to ACP's approved floor plan, current Standards for the Operation of Licensed Pharmacies, inspection record and the buyer's proposed services. Review dispensary security, privacy, consultation, storage, refrigeration, compounding, workflow and shared-premises arrangements.

ACP requires approval before pharmacy renovation begins, and its floor-plan guide applies to ownership changes as well as new, relocated or renovated pharmacies. Existing walls, counters or equipment do not prove the buyer's layout or planned services are compliant.

9. Test lease, property and municipal rights

For a lease, review permitted use, exclusive or prohibited uses, assignment, change of control, landlord consent, guarantees, options, storage, deliveries, security, alterations, restoration and cost. For owned property, investigate title, use, condition, environmental matters, taxes and capital work separately from business value.

Describe every proposed activity—dispensing, retail, clinic or health services, compounding and delivery—and confirm address-specific municipal approvals. A currently operating pharmacy is not proof that a buyer's renovation, co-location, expanded service or signage is permitted.

10. Review systems, staffing and third-party dependencies

Inventory pharmacy-management, Netcare, point-of-sale, payer, wholesaler, compounding, phone, domain, delivery and security systems. Record ownership, interfaces, licences, data rights, service levels, termination, transfer and recredentialing requirements.

Map pharmacists, pharmacy technicians, assistants, delivery and administrative staff, scheduling, compensation, leave and key-person dependencies. Do not assume employment, payer enrolment, wholesaler terms, software access or professional credentials move with the transaction.

11. Convert findings into conditions and closing controls

Coordinate ACP approval, proposed licensee, landlord consent, municipal and premises confirmation, financing, insurance, lien discharges, drug counts, records custody, systems, payer and supplier readiness, staff and possession. Identify objective evidence, responsibility and deadlines for each dependency.

Build a contingency if commercial closing and lawful operating readiness do not align. Possession of the pharmacy, drugs or system credentials does not authorize the buyer to operate, access patient information or dispense.

12. Keep professional conclusions in their proper lane

This guide is educational and is not legal, pharmacy, clinical, health-information, privacy, tax, accounting, employment, planning, building, engineering, appraisal or business-valuation advice. Consult ACP and the applicable professionals for the proposed transaction.

Commercially does not certify pharmacy licences, ownership approval, records transfer, drug inventory, earnings, facility compliance, lease rights or property suitability.